About the Authors

Elise Warcoin

elisewarcoin@gmail.com (EW); francoise.brignole-baudouin@parisdescartes.fr (FB)

Affiliations Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France, CHNO des Quinze-Vingts, Service Pharmacie, Paris, France

Christophe Baudouin

Affiliations Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France, CHNO des Quinze-Vingts, Service III, Paris, France

Carole Gard

Affiliation Horus Pharma, Saint-Laurent du Var, France

Françoise Brignole-Baudouin

elisewarcoin@gmail.com (EW); francoise.brignole-baudouin@parisdescartes.fr (FB)

Affiliations Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France, Faculté de Pharmacie de Paris, Univ Paris Descartes, Sorbonne Paris Cité, Paris, France

Competing Interests

This work was funded by an unrestricted grant from Horus Pharma. Carole Gard is employed by Horus Pharma. Christophe Baudouin: Financial support and consultant (Alcon; Allergan; Santen; Laboratoires Théa). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: EW CB CG FB. Formal analysis: EW FB. Funding acquisition: CB FB. Investigation: EW. Methodology: EW CB FB. Project administration: CB FB. Resources: CG. Supervision: FB CB. Validation: EW FB. Visualization: EW FB. Writing - original draft: EW FB. Writing - review & editing: EW CB CG FB.